JO3600B1 - لقاحات مؤتلفة ل fmdv و استخداماتها - Google Patents
لقاحات مؤتلفة ل fmdv و استخداماتهاInfo
- Publication number
- JO3600B1 JO3600B1 JOP/2015/0240A JOP20150240A JO3600B1 JO 3600 B1 JO3600 B1 JO 3600B1 JO P20150240 A JOP20150240 A JO P20150240A JO 3600 B1 JO3600 B1 JO 3600B1
- Authority
- JO
- Jordan
- Prior art keywords
- fmdv
- vaccine
- vaccines
- recombinant fmdv
- fmdv vaccines
- Prior art date
Links
- 241000710198 Foot-and-mouth disease virus Species 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462054073P | 2014-09-23 | 2014-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO3600B1 true JO3600B1 (ar) | 2020-07-05 |
Family
ID=54256845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2015/0240A JO3600B1 (ar) | 2014-09-23 | 2015-09-28 | لقاحات مؤتلفة ل fmdv و استخداماتها |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10010605B2 (enExample) |
| EP (1) | EP3197486A1 (enExample) |
| JP (1) | JP6931327B2 (enExample) |
| KR (1) | KR102526219B1 (enExample) |
| CN (1) | CN107073100B (enExample) |
| AP (1) | AP2017009834A0 (enExample) |
| AR (1) | AR102006A1 (enExample) |
| AU (2) | AU2015320673B2 (enExample) |
| CA (1) | CA2962225A1 (enExample) |
| JO (1) | JO3600B1 (enExample) |
| MA (1) | MA40151B2 (enExample) |
| MX (1) | MX388708B (enExample) |
| RU (1) | RU2745373C2 (enExample) |
| TW (1) | TWI733653B (enExample) |
| WO (1) | WO2016049209A1 (enExample) |
| ZA (1) | ZA201701851B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017044890A1 (en) * | 2015-09-10 | 2017-03-16 | Academia Sinica | Bird flu vaccine combination comprising virus-like particles and novel adjuvants |
| KR102153303B1 (ko) | 2015-11-23 | 2020-09-09 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | Fmdv 및 e2 융합 단백질 및 이의 용도 |
| TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
| US10172933B2 (en) * | 2016-10-31 | 2019-01-08 | The United States Of America, As Represented By The Secretary Of Agriculture | Mosaic vaccines for serotype a foot-and-mouth disease virus |
| JP7083362B2 (ja) * | 2017-07-12 | 2022-06-10 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | セネカウイルスａ免疫原性組成物およびその方法 |
| CN108103034B (zh) * | 2017-12-15 | 2022-06-24 | 云南农业大学动物医学院 | 同时表达A型、O型和Asia-1型口蹄疫病毒VP1基因重组腺病毒、构建方法及应用 |
| CN108530522B (zh) * | 2018-03-14 | 2021-09-17 | 中华人民共和国汕头海关 | 一种重组的OmpK多表位多肽、构建方法及其应用 |
| CN110467654B (zh) * | 2018-05-11 | 2022-08-09 | 普莱柯生物工程股份有限公司 | 口蹄疫病毒样颗粒抗原、其制备的疫苗组合物及其制备方法和应用 |
| CN111233984B (zh) * | 2018-11-29 | 2022-08-12 | 普莱柯生物工程股份有限公司 | 一种o型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用 |
| JP7303306B2 (ja) * | 2019-01-15 | 2023-07-04 | 普莱柯生物工程股▲ふん▼有限公司 | 口蹄疫ウイルス様粒子抗原及びそのワクチン組成物並びに調製方法及び応用 |
| WO2020263062A1 (ko) * | 2019-06-28 | 2020-12-30 | (주)플럼라인생명과학 | 구제역 바이러스 백신 조성물 |
| CN116685687A (zh) * | 2020-10-22 | 2023-09-01 | 英特维特国际股份有限公司 | 杆状病毒表达载体 |
| EP4232082A1 (en) * | 2020-10-22 | 2023-08-30 | Intervet International B.V. | Baculovirus expression vector |
| US12453767B2 (en) | 2021-08-18 | 2025-10-28 | The United States Of America, As Represented By The Secretary Of Agriculture | Development of mosaic vaccines against foot and mouth disease virus serotype O |
| WO2023020737A1 (en) * | 2021-08-20 | 2023-02-23 | Intervet International B.V. | Fmdv virus-like particle with stabilizing mutation |
| WO2023021168A1 (en) * | 2021-08-20 | 2023-02-23 | Intervet International B.V. | Method of producing a foot and mouth disease virus virus-like particle |
| IL310905A (en) * | 2021-08-20 | 2024-04-01 | Intervet Int Bv | A method for producing a virus-like particle for foot-and-mouth disease virus |
| CN117881424A (zh) * | 2021-08-20 | 2024-04-12 | 珀布赖特研究所 | 具有双稳定突变的fmdv病毒样颗粒 |
| KR102513632B1 (ko) * | 2021-11-30 | 2023-03-28 | 주식회사 왓슨알앤디 | 구제역 바이러스 유사 입자를 생산하기 위한 백신 플랫폼 |
| US12036318B2 (en) * | 2022-02-16 | 2024-07-16 | Chemical & Schutz High Performance Lubricants, S.A. De C.V. | Self-emulsionable mineral oil as a vehicle in vaccines for poultry |
| CN120265316A (zh) | 2022-11-23 | 2025-07-04 | 致优制药有限公司 | 用于生产口蹄疫病毒样颗粒或纳米颗粒的重组表达载体及利用其的疫苗组合物 |
| JP2025538585A (ja) * | 2022-11-23 | 2025-11-28 | オプティファーム カンパニー リミテッド | 口蹄疫ウィルス様粒子またはナノ粒子生産のための組換え発現ベクターおよびこれを用いたワクチン組成物 |
| CN117210501B (zh) * | 2023-09-13 | 2024-06-07 | 中国农业科学院兰州兽医研究所 | 口蹄疫病毒2b蛋白免疫抑制位点突变的重组口蹄疫病毒株的构建 |
| CN117304277B (zh) * | 2023-09-26 | 2024-03-08 | 中国农业科学院兰州兽医研究所 | 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用 |
| US20250134984A1 (en) * | 2023-10-26 | 2025-05-01 | The United States Of America, As Represented By The Secretary Of Agriculture | Development of mosaic vaccines against foot and mouth disease virus serotype asia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA915593B (en) | 1990-07-24 | 1993-03-31 | Novagene Inc | Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same |
| FR2810888B1 (fr) * | 2000-06-29 | 2004-07-30 | Merial Sas | Vaccin contre la fievre aphteuse |
| DK1773387T3 (da) | 2004-06-25 | 2013-07-15 | Merial Ltd | Avipox-rekombinanter der udtrykker mund- og klovesyge-virusgener |
| BRPI0618441B8 (pt) | 2005-11-10 | 2021-07-27 | Genvec Inc | vetor adenoviral |
| JP5309159B2 (ja) * | 2008-01-09 | 2013-10-09 | コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション | バキュロウイルスを利用したワクチン |
| CN101270155B (zh) * | 2008-05-06 | 2011-04-27 | 中国农业科学院兰州兽医研究所 | 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法 |
| GB0810710D0 (en) * | 2008-06-11 | 2008-07-16 | Animal Health Inst | Vaccine |
| US9345759B2 (en) * | 2010-03-12 | 2016-05-24 | Merial, Inc. | Bluetongue virus recombinant vaccines and uses thereof |
| SI3275892T1 (sl) * | 2011-05-13 | 2020-06-30 | Glaxosmithkline Biologicals S.A. | Prefuzijski RSV F antigeni |
| GB201111183D0 (en) * | 2011-06-30 | 2011-08-17 | Animal Health Inst | Peptide |
| IN2014KN02740A (enExample) * | 2012-06-18 | 2015-05-08 | Novartis Ag | |
| US9738689B2 (en) * | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
-
2015
- 2015-09-23 RU RU2017113571A patent/RU2745373C2/ru active
- 2015-09-23 TW TW104131548A patent/TWI733653B/zh active
- 2015-09-23 CA CA2962225A patent/CA2962225A1/en active Pending
- 2015-09-23 WO PCT/US2015/051755 patent/WO2016049209A1/en not_active Ceased
- 2015-09-23 CN CN201580057248.4A patent/CN107073100B/zh active Active
- 2015-09-23 US US14/863,181 patent/US10010605B2/en active Active
- 2015-09-23 MA MA40151A patent/MA40151B2/fr unknown
- 2015-09-23 AP AP2017009834A patent/AP2017009834A0/en unknown
- 2015-09-23 AR ARP150103061A patent/AR102006A1/es active IP Right Grant
- 2015-09-23 EP EP15775553.9A patent/EP3197486A1/en active Pending
- 2015-09-23 MX MX2017003712A patent/MX388708B/es unknown
- 2015-09-23 AU AU2015320673A patent/AU2015320673B2/en active Active
- 2015-09-23 JP JP2017516077A patent/JP6931327B2/ja active Active
- 2015-09-23 KR KR1020177010941A patent/KR102526219B1/ko active Active
- 2015-09-28 JO JOP/2015/0240A patent/JO3600B1/ar active
-
2017
- 2017-03-15 ZA ZA2017/01851A patent/ZA201701851B/en unknown
-
2019
- 2019-07-30 AU AU2019210537A patent/AU2019210537A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2962225A1 (en) | 2016-03-31 |
| AU2019210537A1 (en) | 2019-08-15 |
| AP2017009834A0 (en) | 2017-03-31 |
| US10010605B2 (en) | 2018-07-03 |
| CN107073100A (zh) | 2017-08-18 |
| KR102526219B1 (ko) | 2023-04-26 |
| JP2017530124A (ja) | 2017-10-12 |
| BR112017005833A8 (pt) | 2023-02-14 |
| AU2015320673A1 (en) | 2017-05-11 |
| RU2017113571A3 (enExample) | 2019-04-22 |
| JP6931327B2 (ja) | 2021-09-01 |
| RU2017113571A (ru) | 2018-10-26 |
| ZA201701851B (en) | 2018-05-30 |
| AR102006A1 (es) | 2017-01-25 |
| TWI733653B (zh) | 2021-07-21 |
| AU2015320673B2 (en) | 2019-05-02 |
| BR112017005833A2 (pt) | 2018-02-27 |
| EP3197486A1 (en) | 2017-08-02 |
| MX388708B (es) | 2025-03-20 |
| US20160220659A1 (en) | 2016-08-04 |
| TW201625297A (zh) | 2016-07-16 |
| CN107073100B (zh) | 2021-02-26 |
| WO2016049209A1 (en) | 2016-03-31 |
| KR20170058430A (ko) | 2017-05-26 |
| MA40151A1 (fr) | 2018-01-31 |
| MA40151B2 (fr) | 2022-12-30 |
| RU2745373C2 (ru) | 2021-03-24 |
| MX2017003712A (es) | 2017-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3600B1 (ar) | لقاحات مؤتلفة ل fmdv و استخداماتها | |
| NZ602278A (en) | Bluetongue virus recombinant vaccines and uses thereof | |
| NZ744786A (en) | Recombinant adenovirus vectored fmdv vaccines and uses thereof | |
| MX2017001406A (es) | Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva. | |
| DK3570879T3 (da) | Immunogene sammensætninger til anvendelse i pneumokokvacciner | |
| IL257800A (en) | Immune compositions with improved stability and immunogenicity | |
| DK3244917T3 (da) | Immunogene sammensætninger til anvendelse i pneumokokvacciner | |
| DK3096785T3 (da) | Immunogene sammensætninger omfattende konjugerede kapsel-saccharid-antigener og anvendelser deraf | |
| NZ743236A (en) | Fmdv and e2 fusion proteins and uses thereof | |
| CL2019003805A1 (es) | Composiciones inmunógenas de senecavirus a y métodos de éstas. | |
| ZA201701000B (en) | Attenuated bovine coronavirus and related vaccines | |
| EP3439693A4 (en) | NEW PNEUMOCOCCAL VACCINE FORMULATIONS | |
| EA201690378A1 (ru) | Вакцинные композиции против наркотической зависимости | |
| PH12018500372B1 (en) | Fcv recombinant vaccines and uses thereof | |
| UY36328A (es) | Vacunas de fmdv recombinante y usos de las mismas | |
| EA201691202A1 (ru) | Флагеллин-содержащие белковые наночастицы в качестве платформы для вакцины | |
| TH1701007335A (th) | วิธีการสำหรับการปรับปรุงการดูดซับของคอนจูเกตโพลีแซคคาไรด์-โปรตีน และ สูตรตำรับมัลติวาเลนท์วัคซีนที่ถูกได้มาจากสิ่งนั้น | |
| MX390292B (es) | Vacuna heterologa atenuada viva para leptospira. | |
| TH1601001639A (th) | องค์ประกอบวัคซีนของ pcv2b แบบไดเวอร์เจนท์ และวิธีการใช้งาน |